Lifevantage Corp
LFVNNasdaqHealthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $228.5M | $200.2M | $213.4M | $206.4M | $51.6M | $232.9M |
| Operating income | $12.2M | $4.3M | $4.3M | $7.6M | $17.6M | $15.5M |
| Net income | $9.8M | $2.9M | $2.5M | $3.1M | $1.7M | $11.5M |
| Total assets | $72.0M | $60.3M | $66.1M | $70.7M | $78.7M | $58.9M |
| Total liabilities | $37.3M | $34.3M | $31.5M | $39.2M | $41.9M | $25.6M |
| Equity | $34.6M | $26.0M | $34.6M | $31.5M | $36.8M | $33.3M |
| EPS (diluted) | $0.75 | $0.23 | $0.20 | $0.24 | $0.12 | $0.79 |
| Shares out. | 12.7M | 12.5M | 12.7M | 12.6M | 13.6M | 14.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 5.3%
- Net margin
- 4.3%
- Return on equity
- 28.3%
- Return on assets
- 13.6%
- Return on capital (ROCE)
- 27.3%
- Liabilities / assets
- 51.9%
- Debt / equity
- 1.08×
- Book value / share
- $2.73
- Revenue growth (YoY)
- 14.2%
- Net income growth (YoY)
- 233.8%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -0.45distress
- Accruals / assets
- −2.9%clean
- Beneish M-Score
- -2.54normal
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 5 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 10, 2016
- NT 10-Kmissed a reporting deadline ↗Sep 13, 2016
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Capital Management Corp /VaPassive (13G)Apr 2, 2026
- Blackrock, Inc.Passive (13G)Oct 17, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Neufeld AlissaOfficer — General Counsel | Apr 1, 2026 | Tax withholding | 1,446 | $4.20 |
| Fife Steven ROfficer — President and CEO | Apr 1, 2026 | Tax withholding | 8,180 | $4.20 |
| Aure CarlOfficer — Chief Financial Officer | Apr 1, 2026 | Tax withholding | 1,527 | $4.20 |
| Cunningham KristenOfficer — Chief Sales Officer | Apr 1, 2026 | Tax withholding | 1,928 | $4.20 |
| Lewis DarwinDirector | Mar 16, 2026 | Buy | 1,055 | $5.23 |
| Dayton JuddDirector | Feb 26, 2026 | Buy | 4,600 | $4.58 |
| Lewis DarwinDirector | Feb 9, 2026 | Buy | 3,955 | $5.22 |
| Cunningham KristenOfficer — Chief Sales Officer | Jan 1, 2026 | Tax withholding | 1,926 | $6.16 |
| Neufeld AlissaOfficer — General Counsel | Jan 1, 2026 | Tax withholding | 1,445 | $6.16 |
| Fife Steven ROfficer — President and CEO | Jan 1, 2026 | Tax withholding | 9,169 | $6.16 |
| Aure CarlOfficer — Chief Financial Officer | Jan 1, 2026 | Tax withholding | 1,527 | $6.16 |
| Thompson ToddOfficer — Chief Information Officer | Dec 23, 2025 | Tax withholding | 601 | $6.23 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 3.6M | 13.8 | -6.8% |
| Apr 30, 2026 | 3.9M | 15.0 | +2.8% |
| Apr 15, 2026 | 3.7M | 34.8 | +1.2% |
| Mar 31, 2026 | 3.7M | 44.8 | -0.4% |
| Mar 13, 2026 | 3.7M | 27.8 | -0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 6, 2026
- Director / officer changeApr 16, 2026
- Results of operations · Director / officer changeFeb 4, 2026
- Director / officer changeDec 9, 2025
- Shareholder voteNov 12, 2025
- Results of operationsNov 4, 2025
- Results of operationsSep 4, 2025
- Results of operationsMay 6, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.